Full-cycle support from product development to clinical trials and technological advancement...A total of 15 projects to be selected

The National Institute for Korean Medicine Development (Acting President Song Sujin) announced on the 19th that it will promote an open call for the "Customized Corporate Support for Korean Medicine Product Development" program to strengthen the competitiveness of the Korean medicine industry.


This project is part of establishing a full-cycle support system for the Korean medicine industry, and aims to systematically support the entire process from product development to commercialization, clinical trials, and technological advancement.

Exterior view of the National Institute for Korean Medicine Development

Exterior view of the National Institute for Korean Medicine Development

View original image

The support areas consist of four categories: Korean herbal preparations, convergence and complex Korean medicine, applied products utilizing Korean medicine, and demonstration of Korean medicine medical devices, and a total of 15 projects will be selected.


Starting this year, support will be provided by classifying projects into single-year projects and multi-year (1+1) projects.


Participating companies may apply independently or form a consortium with universities, research institutes, or medical institutions to apply.


Project selection will be conducted through document review and presentation evaluation, comprehensively assessing the feasibility of the development plan, technological development capabilities, and the potential for outcome creation.


A total project budget of 960 million won will be allocated to the selected projects.


The maximum support per project is 80 million won (excluding the self-funded portion).


The main support items include: non-clinical or clinical support for obtaining Investigational New Drug (IND) approval; advancement of prototypes; clinical trial validation and assessment of usability suitability for completed products or prototypes; and revitalization of the regional Korean medicine industry.


The application period runs from the 19th to March 8.


Detailed announcement information can be found on the National Institute for Korean Medicine Development website and on the portal site "Hani-iN."



Acting President Song Sujin said, "We will systematically support product development and corporate growth in the Korean medicine field by actively utilizing the National Institute for Korean Medicine Development's professional personnel and network," adding, "We look forward to strong interest and active participation from companies."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing